Patient Note — 245897

progress_notes_245897_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID245897 (PHI redacted)
Age / Gender36 / Male
Date of Service2026-01-19
ProviderNone
FacilityPOTOMAC UROLOGY CENTER - Manassas
PayerBind Benefits INC
Reason1. Coloplast webinar

Diagnoses

N52.9 Erectile dysfunction, unspecified erectile dysfunction type

Medications

Rosuvastatin Calcium Tadalafil Zepbound(Tirzepatide-Weight Management) Medication List reviewed and reconciled with the patient

Vitals

RR 16.0
HR 95.0
BP 114/72
BMI 29.29
WEIGHT 210 lbs
HEIGHT_IN 71.0

Clinical Summary (HPI)

Erectile Dysfunction screening: 1/19/2026 FU ED Erections 7/10 Good libido Took tadalafil 5 daily with benefit in the past ================================ The patient's previous work-up history is listed below: IPSS: 0 (12/11/24) IIEF: 12 (12/11/24) HgbA1c: WNL Nov'24, no history of DM.

Raw Note (de-identified preview)

4/16/26, 12:47 AM Print Preview [PATIENT_NAME] DOB: [DOB] (36 yo M) Acc No. [ACCOUNT_ID] DOS: 01/19/2026 [PATIENT_NAME] 36 Y old Male, DOB: [DOB] Account: [ACCOUNT_ID]: [PHONE] [ADDRESS] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Bind Benefits INC PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - Manassas 01/19/2026 FU-SameDay: [PROVIDER_NAME], MD Reason for Appointment 1. Coloplast webinar History of Present Illness Erectile Dysfunction screening: 1/19/2026 FU ED Erections 7/10 Good libido Took tadalafil 5 daily with benefit in the past ================================ The patient's previous work-up history is listed below: IPSS: 0 (12/11/24) IIEF: 12 (12/11/24) HgbA1c: WNL Nov'24, no history of DM. Current Medications Taking Rosuvastatin Calcium 20 MG Tablet 1 tablet Orally Once a day Tadalafil 5 MG Tablet 1 tablet Orally Once a day Zepbound(Tirzepatide-Weight Management) 10 MG/0.5ML Solution Auto-injector Subcutaneous Medication List reviewed and reconciled with the patient Past Medical History High Cholesterol. Screening Allergies N.K.D.A. Review of Systems 11 system Review of Systems completed in the chart and all pertinent positives and negatives reviewed with the patient...fp. Vital Signs RR: 16, HR: 95, BP: 114/72 mm Hg, Ht: 71, Wt: 210 lbs, BMI: 29.29 Index. Progress Note: [PROVIDER_NAME], MD 01/19/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:47 AM EDT 1/3 4/16/26, 12:47 AM Print Preview [PATIENT_NAME] DOB: [DOB] (36 yo M) Acc No. [ACCOUNT_ID] DOS: 01/19/2026 Physical Examination GENITOURINARY - MALE: Penis: normal, uncircumcised. Assessments 1.Erectile dysfunction, unspecified erectile dysfunction type - N52.9 (Primary) Treatment 1.Erectile dysfunction, unspecified erectile dysfunction type Start Tadalafil Tablet, 5 MG, 1 tablet, Orally, Once a day, 90 days, 90 Tablet, Refills 3 LAB: TESTOSTERONE Notes: Trial of daily and on demand Tadalafil 5 mg. We discussed the common side effects including but not limited to headache, flushing, syncope, vision changes, nausea, myalgias, dyspepsia, nasal congestion. Discussed penile doppler, benefits including the diagnosis of the cause of his erectile dysfunction, identification of any curvature or plaque, and the efficacy of penile injection therapy. Discussed injection of trimix, and the risks associated, including but not limited to priapism and hematoma, as well as penile curvature with injections over time. The patient voices understanding and they agree to proceed. Check T level Visit Codes [ZIP] Office Visit, Est Pt., Level 4. Electronically signed by [PROVIDER_NAME] MD on 01/19/2026 at 05:18 PM EST Sign off status: Completed [FACILITY] [ADDRESS] STE 220 MANASSAS, VA [ZIP] Progress Note: [PROVIDER_NAME], MD 01/19/2026 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/16